CHANGES IN NEUTROPENIA OUTCOMES FOLLOWING IMPLEMENTATION OF THE CLOZAPINE RISK EVALUATION AND MITIGATION STRATEGY UPDATE

被引：0
|
作者：
Chang, J. [1 ]
Taylor, K. [1 ]
Wei, Y. [1 ]
Huang, T. Y. [1 ]
机构：
[1] Komodo Hlth, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH16
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [31] Changes in Hysterectomy Trends and Patient Outcomes Following the Implementation of a Clinical Pathway
    Mansuria, Suketu M.
    Comerci, John
    Edwards, Robert
    Moghaddam, Amin Sanei
    Ma, Tianzhou
    Linkov, Faina
    OBSTETRICS AND GYNECOLOGY, 2016, 127 : 3S - 3S
  • [32] PILOT TEST OF A DECISION RULE AND IMPLEMENTATION OF AN OUTPATIENT MANAGEMENT STRATEGY FOR LOW RISK PEDIATRIC FEVER AND NEUTROPENIA
    Friedmann, Alison
    Mariani, Juliana
    Rupon, Jeremy
    Talcott, James
    Weinstein, Howard
    Abrams, Annah
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 31 - 31
  • [33] Evaluation of risk evaluation and mitigation strategy compliance in the National Center for Cancer Care and Research Clinics
    Hussein, R.
    Hamad, A.
    Babiker, M.
    Al Hijji, I.
    Hijazi, H.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (03) : 735 - 735
  • [34] Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy
    Gandhi, Gaurang
    Chon, Ashley
    Johnson, Nik
    Kidder, Phyllis A.
    Lee, Peter
    Leung, Kevin
    Ma, Ingrid
    Ness, Stacey
    Sampsel, Elizabeth
    Schlaifer, Marissa
    Seifert, Randall
    Sternaman, Debora B.
    Raval, Kalindi
    JOURNAL OF MANAGED CARE PHARMACY, 2012, 18 (03): : 268 - 275
  • [35] Curbing the Opioid Epidemic in the United States The Risk Evaluation and Mitigation Strategy (REMS)
    Nelson, Lewis S.
    Perrone, Jeanmarie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (05): : 457 - 458
  • [36] Risk evaluation and mitigation strategy for mavacamten: An example demonstrating appropriate safety oversight
    Desai, Milind Y.
    Nissen, Steve E.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024,
  • [37] Implementation and Use of Risk Evaluation and Mitigation Strategies Programs in Practice: A Scoping Review of the Literature
    Tajchman, Sharla
    Lawler, Brooke
    Spence, Nathan
    Haque, Saira
    Quintana, Yuri
    Ateya, Mohammad
    APPLIED CLINICAL INFORMATICS, 2022, 13 (05): : 1151 - 1160
  • [38] Infliximab Risk Evaluation and Mitigation Strategy: Embarking and Executing on the New Era in Drug Safety
    McGowen, J.
    Brajdic, L.
    Patel, S.
    Sarokhan, B.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S408 - S408
  • [39] Risk evaluation and mitigation strategy programs in solid organ transplantation: the promises of information technology
    Tsapepas, Demetra S.
    McKeen, Jaclyn T.
    Martin, Spencer T.
    Walker-McDermott, Jennifer K.
    Yang, Alex
    Hirsch, Jamie
    Mohan, Sumit
    Tiwari, Ruchi
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2014, 21 (E2) : E358 - E362
  • [40] The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities
    Gita A. Toyserkani
    Joann H. Lee
    Esther H. Zhou
    Pharmaceutical Medicine, 2023, 37 : 349 - 353
12345